ProfileGDS5822 / ILMN_1248751
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 18% 17% 9% 28% 21% 13% 50% 18% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 112.318
GSM1276600PDAC Late Ablation Control 21417
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 18.49
GSM1276603PDAC Late Ablation 214.528
GSM1276604PDAC Late Ablation 312.521
GSM1303940PDAC Late Ablation_anti-CTLA4 110.713
GSM1303941PDAC Late Ablation_anti-CTLA4 225.450
GSM1303942PDAC Late Ablation_anti-CTLA4 39.618